Risperdal is an atypical antipsychotic medication prescribed to help patients improve thinking, behavior and mood conditions. With a combination of benzisoxazole and piperidine, it alters the brain’s balance of dopamine and serotonin.
Risperdal was developed by Johnson & Johnson subsidiary Janssen and released in 1994. The FDA has approved it to treat schizophrenia, bipolar disorder and autism in adults and children. Most prescriptions of the drug, however, have been for the unapproved treatment of ADHD in hundreds of thousands of children.
Unfortunately, experts have related Risperdal bad drug side effects to problems like childhood diabetes and gynecomastia.
Gynecomastia is a condition which causes abnormal breast development and sometimes the production of milk. Children as young as 5 years old have developed breasts and adolescent boys have measured breast sizes as large as 38D.
A recent study from Vanderbilt University also found antipsychotic drugs like Risperdal could triple the likelihood of childhood type 2 diabetes, which can lead to vision, skin, hearing and blood pressure problems.
Since Johnson & Johnson failed to adequately warn patients and families about these severe Risperdal bad drug side effects, they are facing liability from those affected. Lawyers have helped hundreds file lawsuits and J&J has already begun paying settlements.
If you or someone in your family developed diabetes or abnormal breasts after using Risperdal, you may qualify for a lawsuit or settlement. Contact us today to speak with a lawyer about your options.
The growth of abnormal breasts from Risperdal may be caused by hyperprolactinemia, a condition where the body produces high levels of the hormone prolactin. Increases in prolactin are usually only found in new mothers who are breastfeeding in order to trigger breast growth and milk production.
However, as a Risperdal bad drug side effect, hyperprolactiemia can lead to breast budding, growth and even milk production in boys and girls as well as adult men. It can also delay the normal male sexual development of puberty and inhibit reproductive functions.
Studies have shown as many as 87% of children taking Risperdal had elevated prolactin levels after only 8 weeks of use. More than 2% were found to have developed abnormal breasts and nearly 1% began producing milk, meaning the conditions could affect thousands of children.
Feminized breast growth and milk production can be especially traumatic to boys and adult men. And with gynecomastia, breast growth is non-reversible, meaning victims often have to endure painful surgery to correct the damage.
Although J & J knew of the dangers of these Risperdal bad drug complications, they hid information deep in the product notes rather than as a prominent side effect warning. They also promoted Risperdal for unapproved use in children, for which they have been fined over $1.2 billion.
Last year J&J earned over $1.4 billion from sales of Risperdal alone. However, they have also settled several lawsuits before reaching trials that would stir negative publicity.
Those affected shouldn’t face these conditions without help from the company that profited. Lawyers are helping patients and families investigate and file claims against the manufacturer, and can discuss your case today at no cost.
Due to the intricate nature of defective drug cases, however, it is important to select a lawyer with experience in this type of lawsuit. DrugRisk only recommends lawyers and law firms that specialize in defective drug litigation and have already handled Risperdal lawsuits.
Contact us today for more information on the warnings, research, side effects and legal action related to Risperdal, or to speak directly with a lawyer. We are available 24 hours a day to help.